Letybo is the most recently FDA-approved neurotoxin on the US market — a refined botulinum toxin type A formulation developed for precise, localized wrinkle treatment. At Body Balance Medical, Teresa Hernandez evaluates your facial anatomy and muscle activity before determining whether Letybo is the right formulation for your goals.
Prefer to send a question first? Contact us directly ↓Letybo (letibotulinumtoxinA-wlbg) earned FDA approval in February 2024 for the treatment of moderate to severe glabellar lines — making it the most recently approved botulinum toxin for cosmetic use in the United States. For the right patient in the right treatment area, its refined diffusion profile offers something the more established formulations don't.
Letybo is designed to stay well-localized at the injection site. It spreads less into surrounding tissue than broader-diffusing formulations, reducing the chance of product reaching adjacent muscle groups. For patients and injectors who prioritize precision, this behavior is a meaningful clinical distinction.
Developed by Hugel, a South Korean biopharmaceutical company, Letybo has an established international track record under the name Botulax before its US market entry. Its 2024 FDA approval reflects a regulatory review of clinical trial data in over 1,200 patients. The formulation represents the latest development in neurotoxin science.
Body Balance Medical is a LegitScript-certified medical practice. Teresa Hernandez, MSN FNP-BC, administers every Letybo injection directly — evaluating your anatomy, muscle activity, and treatment history before placing a single unit.
Letybo is an FDA-approved botulinum toxin type A formulation. Like Botox, Dysport, and Xeomin, it temporarily blocks the nerve signal that triggers muscle contraction — relaxing the targeted muscle and smoothing the skin above it. The clinical mechanism is shared across all neurotoxins in this class. What differs is formulation, diffusion behavior, and the clinical experience behind each product.
Letybo's defining characteristic is its localized diffusion — the product stays close to the injection site rather than spreading broadly through surrounding tissue. This makes it well-suited for areas where precision placement matters and where spread to adjacent muscles would be undesirable. Its onset and duration are comparable to Botox: results typically visible within 3–5 days and lasting 3–4 months.
A full overview of how neurotoxins work across all four formulations is available on our Neurotoxins page. If you're weighing Letybo against other options, the comparison table below covers the key clinical differences.
Letybo is placed in precise amounts at targeted muscle locations using fine-gauge needles. For the FDA-approved glabellar indication, the standard protocol is 20 units across five injection sites.
The botulinum toxin component binds to nerve terminals at the neuromuscular junction and blocks acetylcholine release — the chemical signal that triggers muscle contraction.
With the contraction signal interrupted, the targeted muscle relaxes and the skin above smooths. Letybo's localized diffusion keeps this effect contained to the treated zone.
New nerve endings form over several months and muscle activity returns. Most patients schedule maintenance every 3–4 months, with the FDA recommending no more frequent than every three months for glabellar lines.
Letybo's FDA-approved indication is glabellar lines. Additional treatment areas are addressed off-label based on Teresa's clinical evaluation, your anatomy, and your goals. Its precision diffusion profile makes it particularly well-suited for targeted zones where localized placement is a priority.
The FDA-approved cosmetic indication for Letybo. The vertical creases between the brows caused by repeated corrugator and procerus muscle activity. Standard protocol: 20 units across five injection sites — one in the procerus, two in each corrugator muscle.
Horizontal creases across the forehead caused by repetitive frontalis muscle activity. Treated off-label. Letybo's localized spread makes it precise for the forehead, where unintended diffusion toward the brow can cause heaviness.
Fine lines at the outer corners of the eyes caused by the lateral orbicularis oculi. Treated off-label. Letybo's contained diffusion is well-suited for this area, where staying close to the injection site is an advantage.
Selective relaxation of the muscles that pull the brow tail downward, creating a subtle, non-surgical lift. Precise placement is critical here — Letybo's localized behavior makes it an appropriate choice for this technique.
A small dose along the upper lip border — typically 2–6 units — relaxes the orbicularis oris and causes the upper lip to gently roll outward, increasing visible lip tissue without adding filler volume.
Injecting the masseter muscle reduces bulk from teeth grinding and jaw clenching, refining the lower face. Off-label use. Unit volume and treatment appropriateness are discussed in full during your evaluation.
Diagonal lines across the bridge of the nose caused by the nasalis muscle. A small, precise dose softens these lines — the kind of targeted application where Letybo's localized behavior is a clinical fit.
Visible vertical platysmal bands in the neck respond well to neurotoxin, improving the contour of the neck and the jawline transition. Treated off-label. Unit requirements vary based on muscle prominence.
Overactivity of the mentalis creates a cobblestone texture on the chin surface. A precise, small dose placed at the mentalis smooths the appearance — a subtle refinement that adds definition to the lower face overall.
A Letybo appointment at Body Balance Medical is efficient and thorough. Most patients are in and out in under 45 minutes, including the full evaluation.
Teresa reviews your medical history, prior neurotoxin experience, and treatment goals. She maps your facial muscle activity through a range of expressions to identify precise injection points — and confirms you're a good candidate for Letybo specifically based on your anatomy and treatment history.
The injection itself takes 10–20 minutes. Letybo is administered with fine-gauge needles calibrated to the product's localized diffusion profile. Topical numbing or ice is available on request, though most patients don't require it.
There is no downtime. You can drive, return to work, and resume normal activities immediately. A two-week check-in is recommended to assess your outcome. Minor adjustments within that window are part of the process.
Avoid touching, rubbing, or applying pressure to treated areas. Stay upright for at least four hours. Skip strenuous exercise, saunas, and alcohol for the rest of the day. These precautions keep the product where it was placed.
Minor redness or small marks at injection sites typically resolve within hours. Some patients notice very early signs of muscle softening — though full results take several more days to develop. Don't evaluate early.
Most patients see clear softening of treated areas within three to five days. Glabellar lines typically respond first. Full effect continues developing — wait the full two weeks before assessing your outcome.
Complete results are established by the end of week two. This is the right time to evaluate your outcome. If any area needs a small refinement, contact us — adjustments within this window are available and expected.
Muscle activity returns gradually as the protein is metabolized. Most patients schedule their next treatment before full movement returns. The FDA recommends no more frequently than every three months for the glabellar indication.
All four are FDA-approved botulinum toxin type A formulations with the same core mechanism. The differences in diffusion, onset, and formulation are clinically meaningful. The right choice depends on your anatomy, treatment area, and history. Full details on all four options are on our Neurotoxins page.
| Factor | Letybo | Botox | Dysport | Xeomin |
|---|---|---|---|---|
| Onset | 3 – 5 days | 3 – 7 days | 2 – 3 daysFastest | 3 – 5 days |
| Duration | 3 – 4 months | 3 – 4 months | 3 – 4 months | 3 – 4 months |
| Diffusion | Refined / localizedPrecise | Localized | Broader spread | Localized |
| Unit Ratio | ~1:1 with Botox | Baseline reference | ~2.5–3 per 1 Botox unit | 1:1 with Botox |
| Accessory Proteins | Present | Present | Present | NoneUnique |
| FDA Approval | 2024Newest | 2002 | 2009 | 2011 |
| Best For | Precision areas, patients wanting the newest formulation | First-time patients, predictable results, most clinical data | Broader zones, fastest onset, event timing | Resistance concerns, long-term antibody minimization |
See dedicated pages for Botox, Dysport, and Xeomin for full clinical details on each formulation.
Letybo is priced per unit. Its unit conversion is approximately 1:1 with Botox, making it straightforward to understand if you have prior neurotoxin experience. Your total unit count and investment are determined during your evaluation, based on the areas being treated, your muscle anatomy, and your goals — before anything is scheduled.
If you experience any unexpected symptoms after treatment such as difficulty swallowing, breathing, or speaking, seek medical attention promptly. Teresa reviews your full history and screens for all contraindications before any treatment is planned.
Letybo (letibotulinumtoxinA-wlbg) is the most recently FDA-approved botulinum toxin type A for cosmetic use, cleared in February 2024 for the treatment of moderate to severe glabellar lines. It was developed by Hugel, a South Korean biopharmaceutical company, and has an international track record under the name Botulax prior to its US approval. Its defining clinical characteristic is a refined, localized diffusion profile — it stays close to the injection site rather than spreading broadly into surrounding tissue.
Most patients maintain results for three to four months, consistent with other neurotoxin formulations. Duration is influenced by the area treated, unit volume used, individual metabolism, and muscle activity. The FDA recommends retreatment no more frequently than every three months for the glabellar indication.
Initial softening of expression lines is typically visible within three to five days, with full results developing at 10–14 days. Allow the complete two-week window before evaluating your outcome — and contact us within that window if you'd like a minor adjustment.
Neither is universally better — they share comparable onset (3–5 days), duration (3–4 months), and a localized diffusion profile. Letybo is the newer formulation with a refined precision profile; Botox has decades of clinical data and the most extensive longitudinal safety record of any neurotoxin. For patients who want the newest available formulation and precise localization, Letybo is a strong option. For first-time patients who want the most established track record, Botox often makes sense. Teresa will recommend whichever formulation fits your anatomy and goals.
Dysport has a broader diffusion profile and a faster onset of 2–3 days — advantages for larger muscle groups and time-sensitive situations. Xeomin contains no accessory proteins, which may reduce antibody formation risk over time — the better choice for patients concerned about long-term resistance. Letybo's distinction is its refined, localized diffusion and its status as the newest formulation — a fit for patients who want precision placement and the most recently developed option. See the comparison table above for a full side-by-side.
For the FDA-approved glabellar indication, the standard protocol is 20 units across five injection sites. Off-label areas require different dosing based on muscle strength, treatment area, and anatomy. Letybo's unit conversion is approximately 1:1 with Botox, making it straightforward for patients with prior neurotoxin experience. Teresa provides specific unit recommendations during your evaluation.
Real reviews from Body Balance Medical aesthetics patients — in their own words.
Tell us what you're looking for and our team will reach out to schedule your appointment with Teresa. Select the service you're asking about and we'll route you accordingly.
Prefer to skip the form? Open our scheduler and book directly →
Body Balance Medical is located at 7975 W Sahara Ave, Suite 101, Las Vegas, NV 89117 — serving patients from Summerlin, Spring Valley, Henderson, and the greater Las Vegas area. Same-week appointments are frequently available.
Dermal fillers are a category of injectable treatments — not a single product. What they have in common is that they are placed in the skin or beneath it to support volume, contour, or skin quality in specific areas. What differs is how each achieves that: some add material directly, others prompt the body to produce its own.
This guide answers the three questions that actually matter: is PRP for skin rejuvenation worth it, are you a candidate, and what should you expect from the process. PRP is a treatment that uses your own blood. This is not the service page and not a deep mechanism explainer. It’s a straight read for someone deciding.
Regenerative Aesthetics PRP vs PRF: What’s the Difference and Which
A professional facial at a medical aesthetic clinic is a skin health service. It is performed by a licensed esthetician, it begins with an assessment of your actual skin, and the treatment is matched to your condition rather than chosen from a fixed menu. That distinction changes what a facial can do and how often it makes sense to have one.
Aesthetics · Las Vegas · Medical Aesthetic Services The Rise
Aesthetics · Microneedling · Aftercare Guide Microneedling Aftercare: Dos, Don’ts,
